We’re In The Year Of The Biotech Buyout, And Here Are Five Prime Targets

One catalyst: Big drug companies are running out of ideas, writes Michael Brush.

Topics:  michael   brush   
BING NEWS:
  • Grant Cardone Forecasts Tenfold Returns As Homebuying-Renting Gap Hits 50-Year High
    In 2021, home values spiked as millennials entered prime homebuying age at a time when mortgage rates were historically low. The cost to rent shot up to $2,697 per month while rental prices ...
    05/2/2024 - 1:19 am | View Link
  • Prime Medicine Gets FDA Okay for First Trial of Gene Editing Technique
    The FDA has cleared a clinical trial of an ex vivo prime editing candidate in patients with a rare disease, Prime Medicine announced Monday. The technique taps CRISPR technology to rewrite defective ...
    04/30/2024 - 4:27 am | View Link
  • Daily Digest: Stonestown's upsized housing plans; Why this S.F. company's stock just popped
    The owners of Stonestown Galleria and city officials have agreed to a large package that includes trade-offs and public benefits that would make way for 3,500 housing units on the shopping mall's ...
    04/24/2024 - 4:25 am | View Link
  • Could This Stock Be the Next Biotech Buyout?
    Vertex Pharmaceuticals' $4.9 billion purchase of Alpine Immune Sciences probably won't be the last acquisition of a company focused on kidney disease.
    04/12/2024 - 10:29 pm | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News